BlackRock’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.9M Buy
1,327,282
+82,087
+7% +$293K ﹤0.01% 3933
2026
Q1
$4.27M Buy
1,245,195
+69,161
+6% +$304K ﹤0.01% 3890
2025
Q4
$6.03M Buy
1,176,034
+369,925
+46% +$2.34M ﹤0.01% 3758
2025
Q3
$6.6M Buy
806,109
+264
+0% +$2.25K ﹤0.01% 3651
2025
Q2
$7.35M Sell
805,845
-37,492
-4% -$352K ﹤0.01% 3568
2025
Q1
$8.16M Buy
843,337
+4,103
+0.5% +$49.8K ﹤0.01% 3421
2024
Q4
$11.1M Buy
+839,234
New +$10.3M ﹤0.01% 3374

Other funds holding ALVO

BlackRock's ALVO Position: Q2 2026 in Review

BlackRock increased its Alvotech (ALVO) stake by 6.6% in Q2 2026, buying an estimated $293K and bringing the position to 1,327,282 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3933.

BlackRock first reported a position in ALVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.1M in Q4 2024. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • BlackRock held 1,327,282 shares of Alvotech worth $4.9M as of Q2 2026.
  • BlackRock bought 82,087 Alvotech shares in Q2 2026, an estimated $293K.
  • Alvotech made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3933 holding.
  • BlackRock first reported a position in Alvotech in Q4 2024 and has held it in 7 quarters since.
  • BlackRock's Alvotech position peaked at $11.1M in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.